Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii [Phase 4]
A Phase 4 clinical trial update evaluating the efficacy and safety of Helicobacter pylori therapy with or without Saccharomyces boulardii.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment [Phase 4]
Phase 4 trial update evaluating high-dose amoxicillin and metronidazole plus bismuth for Helicobacter pylori infection (completed).
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy [NA]
Clinical trial comparing reverse hybrid therapy to bismuth quadruple therapy for Helicobacter pylori infection has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori [Phase 4]
Phase 4 trial evaluating broccoli sprout extract and probiotics for eradication of Helicobacter pylori.
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION [Phase 2]
Phase 2 trial update evaluating adding bismuth to standard triple therapy for Helicobacter pylori eradication has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea [NA]
Clinical trial comparing sequential versus quadruple therapy for Helicobacter pylori eradication completed in Korea; results posted in 2019.
-
FDA approval · 2019-05-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original generic application for esomeprazole magnesium, authorizing its use as a proton pump inhibitor. The pro…
-
FDA approval · 2019-05-10FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd., approving the generic product update.
-
FDA approval · 2019-04-25FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (a Pfizer subsidiary).
-
FDA approval · 2019-04-04FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) filed by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection [Phase 4]
Phase 4 trial comparing high-dose dual therapy to bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infec…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection [NA]
Clinical trial update on levofloxacin triple and bismuth quadruple therapies as rescue treatments for Helicobacter pylori infection; study c…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Comparison of Two Rescue Therapies for Helicobacter Pylori Infection [NA]
A completed clinical trial comparing two rescue therapies for Helicobacter pylori infection with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection [Phase 4]
A Phase 4 pilot study evaluating a 14-day modified sequential therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers [Phase 1]
A Phase 1a/b safety study to assess IMX101 in Helicobacter pylori-infected and HP-naive healthy volunteers has completed and will report saf…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection [Phase 4]
An update on a Phase 4 clinical trial evaluating intraluminal clarithromycin powder as monotherapy for Helicobacter pylori infection; the st…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection [Phase 4]
Phase 4 trial evaluating intraluminal metronidazole powder as monotherapy for Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection [Phase 4]
An update on a Phase 4 trial evaluating intraluminal amoxicillin powder as monotherapy for Helicobacter pylori infection, conducted by Macka…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen [Phase 2, Phase 3]
This update notes the completion of Phase 2 and Phase 3 trials comparing a Unani formulation with the standard quintuple therapy for Helicob…
-
CLINICAL_TRIALS research · 2019-02-07Clinical Trial Update: Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
This clinical trial update outlines the post-therapy sample collection protocol for subjects with Helicobacter pylori infection and gastric …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy [NA]
A completed clinical trial (NCT03383003) compared two novel first-line therapies for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: TAK-438 Bismuth Drug Interaction Study [Phase 1]
Phase 1 study update on TAK-438 bismuth drug interaction in Helicobacter pylori infection; results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori [Phase 4]
Phase 4 clinical trial evaluating a modified non-clarithromycin triple therapy for Helicobacter pylori eradication completed.
-
CLINICAL_TRIALS withdrawal · 2018-12-07Clinical Trial Update: Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori [Phase 4]
A Phase 4 trial comparing clarithromycin vs levofloxacin for Helicobacter pylori eradication was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection [Phase 4]
A Phase 4 pilot study evaluating a 14-day modified sequential therapy for Helicobacter pylori infection. Status is unknown.